Novel combinations and targeted pathway inhibitors may improve adherence and blood pressure control in patients with ...

Please provide your email address to receive an email when new articles are posted on . Lifetime risk for hypertension is up to 90% among U.S. adults. Updated guidelines and a pipeline of novel drugs ...